Sanja Dacic, MD, PhD

Pathologist, University of Pittsburgh

Ravi Salgia, MD, PhD

City of Hope Comprehensive Cancer Center,
Duarte, California

Accredited by

American Society of Clinical Oncology

Course Description

Learning Objectives:
- Optimize care for patients with MET amplifications and MET exon 14 deletions.
- Evaluate the use of MET as a therapeutic biomarker.
- Evaluate the effect of therapeutic sequences on tumor evolution and molecular evolution with goal of re-sensitizing the tumor to targeted therapy

Activity Details

Credit Types:CME / MOC / CE
Credit Amount:1.00 Credits
Release Date:2019-Sep-18
Expiration Date:2021-Sep-18
Estimated Time for Completion:1 hour
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.